Back to Search Start Over

A group 3 medulloblastoma stem cell program is maintained by OTX2-mediated alternative splicing

Authors :
Saulnier, Olivier
Zagozewski, Jamie
Liang, Lisa
Hendrikse, Liam D.
Layug, Paul
Gordon, Victor
Aldinger, Kimberly A.
Haldipur, Parthiv
Borlase, Stephanie
Coudière-Morrison, Ludivine
Cai, Ting
Martell, Emma
Gonzales, Naomi M.
Palidwor, Gareth
Porter, Christopher J.
Richard, Stéphane
Sharif, Tanveer
Millen, Kathleen J.
Doble, Brad W.
Taylor, Michael D.
Werbowetski-Ogilvie, Tamra E.
Source :
Nature Cell Biology; August 2024, Vol. 26 Issue: 8 p1233-1246, 14p
Publication Year :
2024

Abstract

OTX2 is a transcription factor and known driver in medulloblastoma (MB), where it is amplified in a subset of tumours and overexpressed in most cases of group 3 and group 4 MB. Here we demonstrate a noncanonical role for OTX2 in group 3 MB alternative splicing. OTX2 associates with the large assembly of splicing regulators complex through protein–protein interactions and regulates a stem cell splicing program. OTX2 can directly or indirectly bind RNA and this may be partially independent of its DNA regulatory functions. OTX2 controls a pro-tumorigenic splicing program that is mirrored in human cerebellar rhombic lip origins. Among the OTX2-regulated differentially spliced genes, PPHLN1is expressed in the most primitive rhombic lip stem cells, and targeting PPHLN1splicing reduces tumour growth and enhances survival in vivo. These findings identify OTX2-mediated alternative splicing as a major determinant of cell fate decisions that drive group 3 MB progression.

Details

Language :
English
ISSN :
14657392 and 14764679
Volume :
26
Issue :
8
Database :
Supplemental Index
Journal :
Nature Cell Biology
Publication Type :
Periodical
Accession number :
ejs66948634
Full Text :
https://doi.org/10.1038/s41556-024-01460-5